National Center for Tumor Diseases
In research, National Center for Tumor Diseases stands highest in Medicine (#1,470 of 10,443 worldwide), Health Sciences (#2,035 of 11,982 worldwide) and Life Sciences (#1,375 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology, Cancer Research and Pulmonary and Respiratory Medicine — Oncology is 14.1× its share of world research.
- World rank, 2022–2025
- #2,614 of 28,054 · #3,898 all time
- Rank in Germany
- #128 of 1,178
- Research works
- 1.7k ▲ 49% vs 2013–17
- Citations
- 58k 34.1 per fractional work
- Top-10% rate
- 28.7% record average 16.5%
- Open access
- 60% world 28%
What is National Center for Tumor Diseases known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,470 of 10,443 | 27.9% | 298 | #1950 | |
| Health SciencesDomain | #2,035 of 11,982 | 27.8% | 310 | #2569 | |
| Life SciencesDomain | #1,375 of 7,800 | 30.9% | 112 | #1741 | |
| OncologySubfield | #315 of 772 | 25.4% | 79 | #427 | |
| Biochemistry, Genetics and Molecular BiologyField | #1,607 of 3,579 | 30.5% | 87 | #2486 |
Each strip is that field’s whole ranked pool, with the notch where National Center for Tumor Diseases sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#1,950 #1,470
- Health Sciences#2,569 #2,035
- Life Sciences#1,741 #1,375
- Oncology#427 #315
- Biochemistry, Genetics and Molecular Biology#2,486 #1,607
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does National Center for Tumor Diseases specialise in?
Where its research is concentrated relative to its size: Oncology takes 14.1× the share of its output that it takes of world research.
- OncologySubfield · 78.9 works14×
- Cancer ResearchSubfield · 20.1 works9.3×
- Pulmonary and Respiratory MedicineSubfield · 47.8 works6.2×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 3.5×. Every wedge is a field page.
- Immunology and Microbiology 3.5×
- Biochemistry, Genetics and Molecular Biology 3.3×
- Medicine 3.1×
- Physics and Astronomy 0.8×
- Health Professions 0.8×
- Economics, Econometrics and Finance 0.8×
- Nursing 0.7×
- Neuroscience 0.6×
- Decision Sciences 0.5×
- Computer Science 0.5×
- Earth and Planetary Sciences 0.5×
- Mathematics 0.4×
- Dentistry 0.4×
- Chemistry 0.3×
- Pharmacology, Toxicology and Pharmaceutics 0.3×
- Engineering 0.2×
- Psychology 0.2×
- Environmental Science 0.1×
- Materials Science 0.1×
- Arts and Humanities 0.1×
- Agricultural and Biological Sciences 0.1×
- Social Sciences 0.0×
- Veterinary 0.0×
- Business, Management and Accounting 0.0×
- Chemical Engineering 0.0×
- Energy 0.0×
Who are the top researchers at National Center for Tumor Diseases?
Ranked on the composite score, Christof von Kalle, Manfred Schmidt and Dirk Jäger lead among researchers whose main affiliation is National Center for Tumor Diseases.
- 1 Christof von Kalle Germany · #7,985 worldwide 920 citations · 68 works
- 2 Manfred Schmidt Germany · #52,154 worldwide 389 citations · 67 works
- 3 Dirk Jäger Germany · #53,476 worldwide 418 citations · 61 works
- 4 Stefanie Speidel Germany · #206,548 worldwide 164 citations · 54 works
- 5 Joachim Wiskemann Germany · #304,674 worldwide 81 citations · 36 works
- 6 Dirk Jaeger Germany · #305,341 worldwide 87 citations · 31 works
- 7 Hans‐Joachim Lück Germany · #355,045 worldwide 52 citations · 24 works
- 8 Dirk Jäger Germany · #457,495 worldwide 102 citations · 32 works
- 9 Sebastian Bodenstedt Germany · #760,502 worldwide 70 citations · 41 works
- 10 Carsten Grüllich Germany · #1,041,885 worldwide 31 citations · 16 works
Which keywords describe research at National Center for Tumor Diseases?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Radiotherapy, Prognostic Factors, Tumor Microenvironment, Cancer, Precision Medicine and Targeted Therapy.
- Tumor Heterogeneity
- Psychosocial Interventions
- Texture Analysis
- Quantitative Analysis
- Immunity
- Glioblastoma
- Predictive Modeling
- PD-1 and PD-L1
- Genomic Instability
- Survival Analysis
- Molecular Classification
- Biomarkers
- Clinical Practice Guidelines
- Genetic Mutations
- Medical Imaging
- Quality of Life
- Precision Medicine
- Prognostic Factors
- Machine Learning
- Chemotherapy
- Immunotherapy
- Cancer
- Radiotherapy
- Tumor Microenvironment
- Targeted Therapy
- Clinical Trials
- Cancer Immunotherapy
- Gene Expression
- Cancer Therapy
- Health-related Quality of Life
- Metastasis
- Neoadjuvant Therapy
- Immune Checkpoint Blockade
- Cancer Survivorship
- Tumor Regression
- Temozolomide
- Lymphoma
- Breast Cancer
- Patient-Reported Outcomes
- Radiomics
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy52▲ 15×18 topics
- Chemotherapy36▲ 10×24 topics
- Cancer30▲ 4.6×45 topics
- Machine Learning29▲ 1.80×23 topics
- Radiotherapy27▲ 14×12 topics
- Prognostic Factors25▲ 12×14 topics
- Tumor Microenvironment25▲ 11×7 topics
- Precision Medicine23▲ 9.9×8 topics
- Targeted Therapy22▲ 20×5 topics
- Quality of Life21▲ 2.9×21 topics
- Clinical Trials19▲ 5.8×15 topics
- Medical Imaging19▲ 7.3×8 topics
- Cancer Immunotherapy15▲ 20×3 topics
- Genetic Mutations15▲ 7.0×20 topics
- Gene Expression15▲ 4.9×14 topics
- Clinical Practice Guidelines15▲ 5.5×11 topics
- Cancer Therapy14▲ 5.1×16 topics
- Biomarkers14▲ 4.1×15 topics
- Health-related Quality of Life14▲ 12×5 topics
- Molecular Classification14▲ 18×4 topics
- Metastasis13▲ 7.8×12 topics
- Survival Analysis13▲ 9.3×6 topics
- Neoadjuvant Therapy12▲ 11×5 topics
- Genomic Instability12▲ 22×3 topics
- Immune Checkpoint Blockade12▲ 22×1 topic
- PD-1 and PD-L112▲ 22×1 topic
- Cancer Survivorship12▲ 33×2 topics
- Predictive Modeling12▲ 8.9×3 topics
- Tumor Regression12▲ 22×2 topics
- Glioblastoma12▲ 35×1 topic
- Temozolomide12▲ 35×1 topic
- Immunity12▲ 5.8×9 topics
- Lymphoma11▲ 14×4 topics
- Quantitative Analysis11▲ 11×3 topics
- Breast Cancer11▲ 9.3×11 topics
- Texture Analysis11▲ 9.4×2 topics
- Patient-Reported Outcomes11▲ 40×1 topic
- Psychosocial Interventions11▲ 40×1 topic
- Radiomics10▲ 17×1 topic
- Tumor Heterogeneity10▲ 17×1 topic
Which research topics does National Center for Tumor Diseases publish most on?
By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, Glioma Diagnosis and Treatment, Cancer survivorship and care and Radiomics and Machine Learning in Medical Imaging.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Immunotherapy and Biomarkers Oncology 12 works
- 2 Glioma Diagnosis and Treatment Genetics 12 works
- 3 Cancer survivorship and care Oncology 11 works
- 4 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 10 works
- 5 Cancer Genomics and Diagnostics Cancer Research 10 works
- 6 CAR-T cell therapy research Oncology 10 works
- 7 Radiation Therapy and Dosimetry Pulmonary and Respiratory Medicine 6 works
- 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 6 works
- 9 Advanced Radiotherapy Techniques Radiation 6 works
- 10 AI in cancer detection Artificial Intelligence 6 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has National Center for Tumor Diseases's research output changed?
Output in 2018–2022 was 49% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Heidelberg
- Heidelberg University
- University Hospital Heidelberg
- German Cancer Research Center
- Max Planck Institute for Nuclear Physics
- Chirurgische Universitätsklinik Heidelberg
- DKFZ-ZMBH Alliance
- Max Planck Institute for Astronomy
- Hautklinik Heidelberg
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.